louisiana glp-1 intestinal paralysis class action Receptor Agonists and Risk of Paralytic Ileus: A drug-target Mendelian Randomization Study glp-1 nausea lawsuit in kentucky

Oral GLP-1 programs remained minimal until the late 2000s, then began rising meaningfully post-2018with the most visible step-up in the last few years: 10 oral programs in 2022, and 11 each in 2024 and 2025

Yu X, Tesiram YA, Towner RA, Abbott A, Patterson E, Huang S, et al

We then determine the appropriate starting dose of Wegovy or Zepbound and gradually transition you from compounded versions to these FDA-approved medications

However, it tends to dry out my skin, so you may want to apply heavy moisturizer or lotion to your skin after using it

The trial found that after 5 years, Wegovy significantly reduced the risk of death from heart disease by 15% and reduced the risk of cardiovascular events including nonfatal heart attacks and strokes by 20%, compared to an inactive placebo